is glp semaglutide Another Weight-Loss Trial Win for Weekly GLP-1 Drug GLP-1s for Weight Loss: What

While the data is promising, it is crucial to remember that Retatrutide is still in Phase 3 development and is not yet commercially available

The study found a drop in mean body weight of 14.9% at 68 weeks

To test this, we pretreated islets with PTX [31]

Clients often report a visible lift in the jawline and neckline within a few weeks

Any effect on GLP-1 appears to be indirect and secondary, with the evidence remaining limited and inconsistent

In the Phase 2 clinical trial published in the New England Journal of Medicine (2023), participants receiving the highest dose of retatrutide reported an average body-weight reduction of about 24% at 48 weeks